(Reuters) – A safety panel of the European drug regulator on Friday recommended adding heavy menstrual bleeding as a side effect of Pfizer Inc/BioNtech’s Comirnaty and Moderna’s Spikevax COVID-19 vaccines.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shailesh Kuber)